Peter Diamandis - 29 Dec 2025 Form 4 Insider Report for Celularity Inc (CELU)

Role: Director
Signature: /s/ Peter Diamandis
Issuer symbol: CELU
Transactions as of: 29 Dec 2025
Transactions value $: $0
Form type: 4
Filing time: 30 Dec 2025, 16:30:27 UTC
Previous filing: 22 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Diamandis Peter	Director	C/O CELULARITY INC., 170 PARK AVENUE, FLORHAM PARK	/s/ Peter Diamandis	30 Dec 2025	0001528288

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CELU	Class A Common Stock	Award	$0	+125,000	+50%	$0	373,765	29 Dec 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CELU	Stock Options	Award	$0	+156,250	+43%	$0	518,774	29 Dec 2025	Class A Common Stock	156,250	$1.2	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
F2	Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
F3	This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.